普米斯生物技术（珠海）有限公司 Biotheus (Zhuhai) Co., Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates 2024-03-15 12:34
Biotheus has entered into a license and collaboration agreement with Hansoh Pharma for its EGFR/MET bispecific antibody in the Greater China territory 2022-11-15 11:16
Biotheus' Bifunctional Therapeutic PM8001 has been Approved by the USFDA to Enter Phase II Studies 2021-12-03 16:23
Biotheus Announces the Closing of a New Round of Financing co-led by General Atlantic and IDG Capital 2021-03-03 11:37
1